Drug
RP L401
RP L401: highest development phase Phase 1, developed by Rocket Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Rocket Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| RP-L401 NCT04525352 | Phase 1 | Infantile Malignant Osteopetrosis |
Latest
No recent events.
Follow RP L401 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.